Dade Behring Holdings News

Donal Quinn has been appointed new head of the Diagnostics division of the Siemens Healthcare Sector. via MediLexicon

If I told you you could invest in the activist fund Third Point at a 6% discount to all other investors - would you be interested? Not only that, but there are no lockups, no minimums, and daily liquidity. via Seeking Alpha

Siemens AG, Europe's largest engineering company, reported its first loss in six years because of costs to sell its automotive division and a penalty tied to a bribery investigation that has engulfed Siemens ... via People's Daily Online

“Becoming the leader in the laboratory diagnostics market enables Siemens to offer its customers a comprehensive portfolio of innovative solutions across the whole healthcare continuum - from prevention to diagnosis, to therapy and care”

As the cash tender offer expired at 12:00 midnight on Oct. 31, 2007, Siemens intends to accept all validly tendered shares of U.S.-based laboratory diagnostics company Dade Behring. via Earth Times

Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. via PR-inside.com

Artes Medical, Inc. , a medical technology company focused on developing, manufacturing and commercializing a new category of aesthetic injectable products for men and women, today announced that Beverly A. ... via Freshnews

“A less tangible opportunity in this acquisition can be the potential retainment of arguably the best management team in the IVD industry”

TRENDS AND PERSPECTIVES Siemens extends reach with Dade Behring purchase Richard Park Siemens AG has once again stunned the IVD industry by signing a merger agreement to acquire Dade Behring Inc. via Medical Device/Diagnostic Ind.

“That's what people were asking 15 years ago, when we were an $11 million business. And there are many more opportunities out there today for Meridian Bioscience than there were back then.”

An email that caught my eye recently was from a gentleman named Forest Albertson. via Fool.com

“At this point, we remain convinced that management's recent restructuring and transition initiatives, combined with a slew of meaningful product launches in the last two years, have positioned the company for sustained financial performance”

Fullerton-based Beckman Coulter Inc.'s 12% stock runup since July is good enough, according to an analyst that downgraded the maker of medical testing gear on Monday. via Orange County Business Journal